TAK

武田製藥

18.74

-0.03-0.16%
After Hours: 18.80  +0.06  +0.32%18:24 04/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE18.56/18.77
TODAY RANGE18.46-18.83
VOL2.64M
MARKET CAP59.21B
52 WEEK RANGE12.77-18.90
AVG VOL (3M)3.04M
% TURNOVER0.08%
TURNOVER--
P/E (TTM)81.06
% RANGE1.97%
EPS(TTM)0.2312
P/E(FORWARD)60.45
P/B1.210
BVPS15.48
DIVIDEND0.6612
P/S1.921
BETA--
DIV YIELD3.53%
FREE FLOAT MKT CAP59.21B
SHARES OUTSTANDING3.16B
NEXT EARNINGS01/28-02/02
FREE FLOAT3.16B
LOT SIZE1
EX-DATE09/30/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

武田製藥

TAK

-0.16%
18.74

MCK

--

BIIB

--

A

Amgen Inc

AMGN

-1.51%
347.94

SHPG

--

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+34.65%
0.1193

LLY

--

C

Celgene

CELG

0.00%
108.24

TXMD

--

JNJ

--

A

Abbvie Inc

ABBV

-2.86%
208.84

ZTS

--

GILD

--

N

Novo-Nordisk A/S

NVO

+1.37%
36.98

B

Bristol-Myers Squibb Co

BMY

-2.46%
59.60

ALXN

--

PFE

--

SNY

--

GCVRZ

--

NVS

--

如瑞迪博士

RDY

-1.11%
13.32

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.